BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ocata Therapeutics (Formerly Known As Advanced Cell Technology) 

33 Locke Drive

Marlborough  Massachusetts   01752  U.S.A.
Phone: 580-756-1212 Fax: 580-229-2333


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Ocata Therapeutics To Present At The Jefferies and Co. 2015 Global Healthcare Conference 5/18/2015 11:52:25 AM
Dr Robert Lanza, Chief Scientific Officer Of Ocata Therapeutics To Be A Featured Speaker At The Common Good Forum 5/11/2015 11:59:47 AM
Ocata Therapeutics Announces Positive Results In Treating Macular Degeneration Using Fully Differentiated Stem Cell-Derived Retinal Pigment Epithelium (RPE) Cells In Asian Patients 4/30/2015 10:51:43 AM
Ocata Therapeutics To Host Conference Call And Webcast To Provide Corporate Update For The Fourth Quarter And Full Year Of 2014 3/11/2015 10:54:49 AM
Advanced Cell Technology Changes Name To Ocata Therapeutics 11/14/2014 10:51:48 AM
Advanced Cell Technology To Host Conference Call And Webcast To Provide A Corporate Update For The Third Quarter Of 2014 11/7/2014 9:40:50 AM
Advanced Cell Technology Appoints Leroux Jooste As SVP Of Business Development & Chief Commercial Officer 10/20/2014 9:44:38 AM
Advanced Cell Technology Reports The Publication Of Research On The Scalable Generation Of Universal Platelets From Human Induced Pluripotent Stem Cells (iPSC) 10/17/2014 7:43:28 AM
Advanced Cell Technology Announces Positive Results from Two Clinical Trials Published In Lancet Using Differentiated Stem Cell-Derived Retinal Pigment Epithelium (RPE) Cells For The Treatment Of Macular Degeneration 10/15/2014 11:05:51 AM
Advanced Cell Technology Announces Final Patient Treated In Stargardt’s Macular Degeneration Phase 1 Trial In The United Kingdom 9/25/2014 8:42:31 AM
12345678910...